Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 3495
Single User License Price INR 251291
Corporate User License Price USD 10485
Corporate User License Price INR 753872
Site License Price USD 6990
Site License Price INR 502581
Request a Quote

Report Title

Hepatitis C: Competitive Landscape to 2026

Quote Request for License Type
License Type Price  
Single User License USD 3495
Site License USD 6990
Enterprise Wide License USD 10485
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Hepatitis C: Competitive Landscape to 2026


Quote Request for License Type
License Type Price  
Single User License USD 3495
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Hepatitis C: Competitive Landscape to 2026

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Hepatitis C: Competitive Landscape to 2026



Executive Summary

Hepatitis C: Competitive Landscape to 2026

Summary

Hepatitis C is a liver infection caused by the hepatitis C virus (HCV), a small enveloped RNA virus. If left untreated, chronic infection can result in fibrosis, cirrhosis, hepatocellular carcinoma, and eventually death. HCV is spread primarily by exposure to infected blood.

This report provides an assessment of the pipeline, clinical, and commercial landscape of hepatitis C. Overall, GlobalData expects next-generation direc-acting antiviral (DAA) regimens to drive growth, with opportunities for new entrants residing primarily in emerging markets (Brazil and China) over the next decade (2016-2026).

Scope

This report combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace. Components of the slide deck include-

- Pipeline Assessment: regional breakdown, promising late-stage products, early-stage pipeline by molecule type

- Clinical Trials Assessment: trial breakdown by phase, leading industry and non-industry sponsors, enrollment analytics

- Commercial Assessment: leading marketed products, current and future players

- Competitive Landscape Analysis: key market events (2016-2026).

Reasons to buy

- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.

- Develop business strategies by understanding the trends shaping and driving the global hepatitis C market.

- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global hepatitis C market in the future.

- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Table of Contents

1. Preface 2

1.1 Table of Contents 2

1.2 Abbreviations 3

1.3 Related Reports 4

1.4 Upcoming Related Reports 5

2. Executive Summary 6

2.1 Key Findings 7

2.2 Key Events 8

3. Introduction 9

3.1 Report Scope 10

3.2 Disease Overview and Epidemiology 12

4. Pipeline Assessment 16

4.1 Pipeline Overview 17

4.2 Pipeline Breakdown by Region/Country 19

4.3 Pipeline Breakdown by Molecule Type and Target 20

4.4 Drug Review Designations 21

4.5 Products in Clinical Development 22

5. Clinical Trial Assessment 24

5.1 Clinical Trials Overview 25

5.2 Top Sponsors of Clinical Trials in MRSA 26

5.3 Trial Breakdown by Region 28

5.4 Therapy Area Perspective 29

5.5 Enrollment Analytics 30

6 Commercial Assessment 33

6.1 Leading Marketed Products 34

6.2 Current & Future Players 35

7. Competitive Landscape Analysis (2016-2026) 36

7.1 Events Classification Overview 37

7.2 7MM 38

7.3 Emerging Markets (Brazil and China) 39

8 Appendix 40

8.1 Sources 41

8.2 Methodology 42

8.3 Key Events Included in the Analysis 43

8.4 About the Authors 44

8.5 About GlobalData 47

8.6 Disclaimer 49

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Gilead Sciences

AbbVie

Merck & Co

Bristol-Myers Squib

Ascletis

Roche

Beijing Kawin Technology

Biotest Pharmaceuticals

Xiamen Amoytop Biotech

Dongguan HEC TaiGen


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand